Charles river laboratories to acquire vigene biosciences to enhance gene therapy capabilities

Wilmington, mass.--(business wire)---- $crl--charles river laboratories to acquire vigene biosciences, a premier cell and gene therapy cdmo providing viral vector-based gene delivery solutions

CRL Ratings Summary

CRL Quant Ranking